Court Extends Pre-Trial Order Deadline In Plavix Patent Suit
A federal court has extended the pre-trial order submission deadline in a patent challenge to Sanofi-Aventis' blood-thinning drug Plavix....To view the full article, register now.
Already a subscriber? Click here to view full article